New Data Examine Pediatric ADHD Medication Prior Authorization Policies in Medicaid Managed Care Plans 

 ADHD in the News 2026-09-17


PHILADELPHIA, September 10, 2026 — New data published by the Center for Public Health Law Research (CPHLR) at Temple University Beasley School of Law offers an in-depth look at prior authorization policies applying to children under the age of 18 in Medicaid managed care plans. It captures details of Medicaid managed care policies for the 50 U.S. states and the District of Columbia, describing policies around access to ADHD medications as of October 1, 2025, including prior authorization and age requirements and prerequisites of non-medication alternatives.

View Article: Temple University Center for Public Health Law Research, September 10, 2026




Other Articles in this Edition

Peer Exchange: Managing Adult ADHD: Addressing Diagnosis, Treatment Selection, and All-Day Symptom Control

Fractured Trust, Delayed Care: What Rising Health Misinformation Means for ADHD

ADHD Could Raise Odds For Gut Problems

Study suggests the profile of people diagnosed with ADHD and autism has changed over the past decade 

Multilingual girls face delayed ADHD diagnosis and support 

New Adult ADHD Guidelines: What Resources Are Coming Soon 

Tisha Campbell Reveals Her Autism And ADHD Diagnosis At 57 

Using ‘neurodivergent’ as a catch‑all term is problematic – here’s why 

Should Primary Care Take on a Greater Role in the Care of ADHD? 

New Data Examine Pediatric ADHD Medication Prior Authorization Policies in Medicaid Managed Care Plans 

Visual aids help school-aged children with ADHD recount stories 

ESCRS 2026: The eye as a window into ADHD: emerging evidence and practical implications 

Unintentional mind wandering disrupts attention in ADHD through two different mechanisms